Skip to NavigationSkip to content

Pharmafile.com's weekly COVID-19 news round-up

Published on 26/08/20 at 10:07am
Photo by the CDC

In COVID-19 news this week, China is set to move ahead with human testing of a potential coronavirus vaccine that has been created using insect cells while Australia has signed its first deal to secure doses of a potential vaccine for its citizens, inking a partnership with AstraZeneca and the University of Oxford.

In treatment related news, the FDA could expand its Emergency Use Authorization (EUA) for Gilead’s remdesivir for treating coronavirus patients while AstraZeneca has started a clinical trial of its antibody treatment designed to prevent and also treat symptoms of the virus.

1. AstraZeneca begins antibody COVID-19 treatment trial in the UKPublished on 25/08/20

AstraZeneca has started a clinical trial of its antibody treatment designed to prevent and also treat symptoms of coronavirus.

2. China’s ‘insect’ vaccine for COVID-19 approved for human testingPublished on 24/08/20

China is set to move ahead with human testing of a potential coronavirus vaccine that has been created using insect cells.

3. Gilead says FDA could expand eligibility of coronavirus patients for remdesivirPublished on 24/08/20

The FDA could expand its Emergency Use Authorization (EUA) for Gilead’s remdesivir for treating coronavirus patients, according to Gilead.

4. Australia signs first COVID-19 vaccine deal for 25 million doses of AstraZeneca/Oxford University candidatePublished on 19/08/20

Australia has signed its first deal to secure doses of a potential COVID-19 vaccine for its citizens, inking a partnership with AstraZeneca and the University of Oxford for their jointly developed candidate known as ChAdOx1.

5. UK Government officially announces National Institute for Health Protection to replace Public Health EnglandPublished 19/08/20

The UK Government has officially announced that Public Health England will be replaced by the National Institute for Health Protection.

 

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches